Literature DB >> 19106613

Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma.

Roberta Ciarapica, Guiseppe Russo, Federica Verginelli, Lavinia Raimondi, Alberto Donfrancesco, Rosella Rota, Antonio Giordano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19106613     DOI： 10.4161/cc.8.1.7292

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  66 in total

1.  Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state.

Authors:  Min-Hyung Lee; Mathivanan Jothi; Andrei V Gudkov; Asoke K Mal
Journal:  Cancer Res       Date:  2011-04-14       Impact factor: 12.701

2.  Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.

Authors:  Alexandros Tzatsos; Polina Paskaleva; Stephania Lymperi; Gianmarco Contino; Svetlana Stoykova; Zhao Chen; Kwok-Kin Wong; Nabeel Bardeesy
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

3.  Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.

Authors:  Petr Dmitriev; Luiza Stankevicins; Eugenie Ansseau; Andrei Petrov; Ana Barat; Philippe Dessen; Thomas Robert; Ahmed Turki; Vladimir Lazar; Emmanuel Labourer; Alexandra Belayew; Gilles Carnac; Dalila Laoudj-Chenivesse; Marc Lipinski; Yegor S Vassetzky
Journal:  J Biol Chem       Date:  2013-10-20       Impact factor: 5.157

4.  SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.

Authors:  Davide Martino Coda; Marcello Francesco Lingua; Deborah Morena; Valentina Foglizzo; Francesca Bersani; Ugo Ala; Carola Ponzetto; Riccardo Taulli
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.

Authors:  Pradeep Kumar Kopparapu; Sujata Bhoi; Larry Mansouri; Laleh S Arabanian; Karla Plevova; Sarka Pospisilova; Agata M Wasik; Giorgio Alberto Croci; Birgitta Sander; Marco Paulli; Richard Rosenquist; Meena Kanduri
Journal:  Epigenetics       Date:  2016-04-06       Impact factor: 4.528

Review 6.  MicroRNAs in skeletal myogenesis.

Authors:  Yejing Ge; Jie Chen
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

Review 7.  Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.

Authors:  Roberta Ciarapica; Lucio Miele; Antonio Giordano; Franco Locatelli; Rossella Rota
Journal:  BMC Med       Date:  2011-05-25       Impact factor: 8.775

Review 8.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

9.  The role of miR-26 in tumors and normal tissues (Review).

Authors:  Jie Gao; Qing-Guang Liu
Journal:  Oncol Lett       Date:  2011-09-05       Impact factor: 2.967

10.  Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.

Authors:  Roberta Ciarapica; Elena Carcarino; Laura Adesso; Maria De Salvo; Giorgia Bracaglia; Pier Paolo Leoncini; Alessandra Dall'agnese; Federica Verginelli; Giuseppe M Milano; Renata Boldrini; Alessandro Inserra; Stefano Stifani; Isabella Screpanti; Victor E Marquez; Sergio Valente; Antonello Mai; Pier Lorenzo Puri; Franco Locatelli; Daniela Palacios; Rossella Rota
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.